2 withdrawn, 1 completed. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Withdrawn 2, Completed 1 |
Follow Malignancy: new trials by email Literature Review of Malignancy trials Research Report on Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients 68Ga-FAPI-46 - Solid Tumor Cancer, Solid Tumor Malignancy | Early Phase 1 | Withdrawn | Eben Rosenthal | 2027-01-01 | 2026-01-21 | |
| Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent Ureteral Stent, Percutaneous Nephrostomy Tube Placement - Cancer, Urinary Obstruction | Early Phase 1 | Withdrawn | University of Chicago | 2023-09-22 | 2024-12-19 | |
| Immune Response to the COVID-19 Vaccine SARS-COV2 Pfizer Vaccine - Covid19, Cancer | Early Phase 1 | Completed | University of Arizona | 20 | 2021-06-07 | 2022-05-20 |
Neoplasms (3) · COVID-19 (1) · Ureteral Obstruction (1)
Coronaviridae Infections (1) · Coronavirus Infections (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Infections (1) · Lung Diseases (1) · Male Urogenital Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Ureteral Diseases (1) · Urogenital Diseases (1)
FAPI-46 (1)
Eben Rosenthal (1) · University of Arizona (1) · University of Chicago (1)
United States (3)
Eben Rosenthal, MD (1) · Parth Modi, MD (1) · Rachna Shroff, MD (1)